…minantly stereotactic radiosurgery (SRS)) followed by continued osimertinib, with encouraging PFS/OS and acceptable toxicity. By contrast, …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 3 of 2459…ess, we found some positive exemplars. Guidelines for epilepsy, chronic obstructive pulmonary disease, depression, and tuberculosis went beyond generic statements, i…
…EM+COBI; for purposes of the analyses, the missing category and ECOG performance status of 1 were pooled, resulting in a conservative approach for the …
… (15.52) Systolic ≥140 mm Hg or diastolic ≥90 mm Hg1706 (3.13) Aspirin1210 (2.22)Pregnancy outcomes: Median (IQR) gestational age at deliv…
…ypically delivered 5 days a week over 7 weeks concurrently with cisplatin, a regimen established through multiple randomised trials, demo…
…lly for populations where wearability is a barrier.Introduction Type 1 diabetes affects individuals of all ages globally, with its prevalence s…
…he lower risk of death from cardiovascular disease, cancer, and respiratory disease largely plateaued after reaching about 20 MET hours/week of tot…
…1D at age 50 was 4.9 years for men and 6.9 years for women. For T2D, YLL at the same age was 4.9 years for men and 5.7 years for wo…
…patient in sitravatinib+tislelizumab arm; 13 (6.8%) patients in docetaxel arm) (figure 1). One patient randomised to sitravatinib+tisleli…
…onists; SGLT-2i, sodium-glucose cotransporter-2 inhibitors; TC, thyroid cancer.The results for the secondary analyses based on the three addit…
…stic.To determine predictors for histopathological diagnosis of DKD, binary logistic regression analysis was performed, considering…